Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-29

Clinical Trial Update: Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence [NA]

View source ↗

Summary

This clinical trial compares a spectrometry-based method (MRM) to the I-125 radioimmunoassay for quantifying Orexin-A in patients with hypersomnolence, includin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Narcolepsy, Idiopathic Hypersomnia | NA | Status: RECRUITING